Genmab falls 4.8% after cancer drug trial fails to meet goal

Monday, Jan 19, 2026 3:04 am ET1min read
GMAB--

Genmab falls 4.8% after cancer drug trial fails to meet goal

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet